Company / Depreciation & Amortization
PROKIDNEY CORP. Depreciation & Amortization History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$5.4M
FY2024
5-year range
$964.0K / $5.4M
FY2020-FY2024
Trend
+41.0%
vs FY2023
Sector context
#77 of 168
Health Care
What the data says
At $5M, PROKIDNEY CORP.'s depreciation & amortization ranks #92 of 168 in the Health Care sector. Depreciation & Amortization has increased for 4 consecutive years, from $964,000 in FY2020 to $5M in FY2024.
Based on SEC 10-K filings.
$5M in FY2024 with a 3-year CAGR of +39.9%.
Increased from $3M to $5M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +39.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#92 of 168 in Health CareTop 54% of 168This company $5.4M Sector average $212.9M
▼
-97.4% below sector average
Key checks
Key Insights
- PROKIDNEY CORP.'s depreciation & amortization has grown for 4 consecutive years.
- 3-year CAGR of +39.9%, indicating consistent growth.
- In FY2024, depreciation & amortization increased 41.0% year-over-year.
- Ranks #77 out of 168 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -1.00 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $5.4M | +41.0% |
| FY2023 | $3.9M | +26.9% |
| FY2022 | $3.0M | +53.0% |
| FY2021 | $2.0M | +105.8% |
| FY2020 | $964.0K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026